Panel discussion.

27 May 2018 (13:20 - 13:40)

Organised by:

About the speaker

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

4 More presentations in this session

Presentation thumbnail

Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors? - Introduction

Professor J. Cleland (Glasgow, GB)

Presentation thumbnail

Renin-angiotensin-aldosterone system inhibitors therapy benefits and challenges in cardio-renal patients.

Professor P. Van Der Meer (Groningen, NL)

Presentation thumbnail

Changing the treatment paradigm of hyperkalaemia management to enable and optimize renin-angiotensin-aldosterone system inhibitors therapy.

Professor B. Pitt (Ann Arbor, US)

Presentation thumbnail

Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors? - Summary and conclusions

Professor J. Cleland (Glasgow, GB)

Access the full session

Session thumbnail

Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors?

The Event

Heart Failure 2018

27 May 2018 13:20 CET

You may be interested in

Congress Session

A new era in the management of patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) and cardiovascular complications

31 August 2024

Congress Presentation

Introduction

30 August 2025

Congress Session

Real-world experience from an MDT cardiometabolic clinic

23 June 2023

Congress Session

Optimising cardiovascular risk prediction and management in patients with renal disease

4 April 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources